申请人:Chai Tai Tianqing Pharmaceutical Group Co., Ltd.
公开号:EP3418282A1
公开(公告)日:2018-12-26
Provided are compounds of formula I and formula II or pharmaceutically acceptable salts of the compounds and pharmaceutical compositions thereof. The compounds of formula I and formula II or the pharmaceutically acceptable salts of the compounds provide indole 2,3-dioxygenase (IDO) inhibitory activity and are capable of treating IDO-mediated immunosuppressive diseases, such as infectious diseases or cancer.
本文提供了式 I 和式 II 的化合物或其药学上可接受的盐及其药物组合物。式 I 和式 II 的化合物或其药学上可接受的盐具有吲哚-2,3-二氧合酶(IDO)抑制活性,能够治疗 IDO 介导的免疫抑制疾病,如传染性疾病或癌症。